3rd generation glp 1 agonist Mazdutide vs retatrutide: dual meets triple agonist in the next-gen weight loss showdown Lindsay Maggio, MD, MPH |
Description
doi: 10.1016/j.molmet.2022.101586
Food preferences also shift for many users
Yang, Y

Cycling has practical advantages

Figure was created by the author

However, the GLP-1 medications have some pretty intense side effects
